PRESS RELEASE published on 10/01/2024 at 13:39, 2 years ago Information mensuelle sur le contrat de liquidité et sur le nombre total de droits de vote Novacyt publie son bilan mensuel du contrat de liquidité et du nombre total de droits de vote. Consultez les détails de l'opération et les contacts clés de l'entreprise Contrat Droits De Vote Liquidité Actions Ordinaires Novacyt
PRESS RELEASE published on 10/01/2024 at 13:36, 2 years ago Liquidity Agreement Monthly Update and Total Voting Rights Novacyt provides a monthly update on its liquidity agreement with Invest Securities SA and discloses total voting rights. The agreement involves purchasing and selling ordinary shares under French law Liquidity Agreement Total Voting Rights French Law Novacyt Invest Securities SA
PRESS RELEASE published on 09/17/2024 at 10:28, 2 years ago Lancement du nouveau site web Novacyt annonce le lancement de son nouveau site web, offrant un large portefeuille de services de diagnostic moléculaire. Visitez www.novacyt.com pour en savoir plus Technologies Investisseurs Site Web Diagnostic Moléculaire Novacyt
BRIEF published on 09/17/2024 at 10:27, 2 years ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
BRIEF published on 09/17/2024 at 10:27, 2 years ago Novacyt annonce ses résultats du premier semestre 2024 et un webinaire destiné aux investisseurs Résultats Financiers Webinaire Presentation Aux Investisseurs Diagnostic Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 2 years ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:24, 2 years ago Information sur les résultats du 1er semestre 2024 et présentation aux investisseurs Novacyt annonce ses résultats du 1er semestre 2024 et une présentation aux investisseurs le 26 septembre 2024. Webinaire interactif avec Lyn Rees et Steve Gibson Résultats Semestriels Webinaire Investisseurs Diagnostic Moléculaire Novacyt
PRESS RELEASE published on 09/17/2024 at 10:22, 2 years ago Notice of Half Year 2024 Results and Investor Presentation Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
BRIEF published on 09/06/2024 at 11:51, 2 years ago Novacyt : Bilan Mensuel du Contrat de Liquidité et Droits de Vote Contrat De Liquidité Droits De Vote INVEST SECURITIES Actions Ordinaires Novacyt
BRIEF published on 09/06/2024 at 11:51, 2 years ago Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
Published on 10/03/2026 at 02:35, 4 hours 27 minutes ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 17 hours 12 minutes ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 18 hours 2 minutes ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 18 hours 2 minutes ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/02/2026 at 23:55, 7 hours 7 minutes ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 10 hours 38 minutes ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 11 hours 16 minutes ago innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 12 hours 2 minutes ago INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 10/02/2026 at 18:00, 13 hours 2 minutes ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 13 hours 17 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 13 hours 17 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 13 hours 27 minutes ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 13 hours 32 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 13 hours 32 minutes ago Aéroports de Paris SA - Calendrier financier 2027
